Date Filed | Type | Description |
06/30/2023 |
4
| ALTOMARI ALFRED (CEO) has filed a Form 4 on AGILE THERAPEUTICS INC
Txns:
| Granted 37,500 shares
@ $0 Granted 8,963 shares
@ $0 Granted 12,500 options to buy
@ $2.48, valued at
$31k
|
|
11/14/2022 |
4
| ALTOMARI ALFRED (CEO) has filed a Form 4 on AGILE THERAPEUTICS INC
Txns:
| Granted 30,000 options to buy
@ $0.2, valued at
$6k
|
|
08/29/2022 |
4
| ALTOMARI ALFRED (CEO) has filed a Form 4 on AGILE THERAPEUTICS INC
Txns:
| Bought 50,000 shares
@ $0.45, valued at
$22.5k
|
|
05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/20/2022 |
4
| ALTOMARI ALFRED (CEO) has filed a Form 4 on AGILE THERAPEUTICS INC
Txns:
| Granted 675,000 options to buy
@ $0.342, valued at
$230.9k
|
|
10/14/2021 |
4
| ALTOMARI ALFRED (CEO) has filed a Form 4 on AGILE THERAPEUTICS INC
Txns:
| Bought 58,824 shares
@ $0 Bought 29,412 warrants
@ $0.85, valued at
$25k
|
|
07/29/2021 |
4
| ALTOMARI ALFRED (CEO) has filed a Form 4 on AGILE THERAPEUTICS INC
Txns:
| Bought 26,200 shares
@ $1.2632, valued at
$33.1k
|
|
05/19/2021 |
4
| ALTOMARI ALFRED (CEO) has filed a Form 4 on AGILE THERAPEUTICS INC
Txns:
| Bought 20,000 shares
@ $1.61, valued at
$32.2k
|
|
05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/23/2021 |
4
| ALTOMARI ALFRED (CEO) has filed a Form 4 on AGILE THERAPEUTICS INC
Txns:
| Bought 12,500 shares
@ $2.0024, valued at
$25k
|
|
01/28/2021 |
4
| ALTOMARI ALFRED (CEO) has filed a Form 4 on AGILE THERAPEUTICS INC
Txns:
| Granted 692,641 options to buy
@ $2.82, valued at
$2M
|
|
12/09/2020 |
4
| ALTOMARI ALFRED (Director) has filed a Form 4 on INSMED Inc
Txns:
| Sold 20,000 shares
@ $39.57, valued at
$791.4k
|
|
08/20/2020 |
4
| ALTOMARI ALFRED (CEO) has filed a Form 4 on AGILE THERAPEUTICS INC
Txns:
| Exercised 94,599 options to buy
@ $1.76, valued at
$166.5k
|
|
06/23/2020 |
4
| ALTOMARI ALFRED (CEO) has filed a Form 4 on AGILE THERAPEUTICS INC
Txns:
| Exercised 50,000 options to buy
@ $1.76, valued at
$88k
|
|
05/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/27/2020 |
4
| ALTOMARI ALFRED (Director) has filed a Form 4 on Baudax Bio, Inc.
Txns:
| Bought 5,000 shares
@ $2.34, valued at
$11.7k
|
|
02/27/2020 |
4
| ALTOMARI ALFRED (CEO) has filed a Form 4 on AGILE THERAPEUTICS INC
Txns:
| Bought 10,000 shares
@ $2.71, valued at
$27.1k
Exercised 16,541 options to buy
@ $0.71, valued at
$11.7k
|
|
01/24/2020 |
4
| ALTOMARI ALFRED (CEO) has filed a Form 4 on AGILE THERAPEUTICS INC
Txns:
| Granted 26,502 shares
@ $0 Granted 833,333 options to buy
@ $2.83, valued at
$2.4M
|
|
12/09/2019 |
4
| ALTOMARI ALFRED (Director) has filed a Form 4 on Recro Pharma, Inc.
Txns:
| Granted 15,284 shares
@ $0 |
|
12/09/2019 |
4
| ALTOMARI ALFRED (Director) has filed a Form 4 on Baudax Bio, Inc.
Txns:
| Granted 20,000 shares
@ $0 |
|
12/02/2019 |
3
| ALTOMARI ALFRED (Director) has filed a Form 3 on Baudax Bio, Inc. |
06/11/2019 |
4
| ALTOMARI ALFRED (CEO) has filed a Form 4 on AGILE THERAPEUTICS INC
Txns:
| Bought 20,000 shares
@ $1.27, valued at
$25.4k
|
|
05/16/2019 |
4
| ALTOMARI ALFRED (Director) has filed a Form 4 on INSMED Inc
Txns:
| Granted 6,899 shares
@ $0 |
|
05/10/2019 |
4
| ALTOMARI ALFRED (Director) has filed a Form 4 on Recro Pharma, Inc.
Txns:
| Granted 7,955 shares
@ $0 Granted 10,888 options to buy
@ $8.8, valued at
$95.8k
|
|
04/01/2019 |
4/A
| ALTOMARI ALFRED (CEO) has filed a Form 4 on AGILE THERAPEUTICS INC
Txns:
| Bought 25,000 shares
@ $1.54, valued at
$38.5k
|
|
03/26/2019 |
4
| ALTOMARI ALFRED (CEO) has filed a Form 4 on AGILE THERAPEUTICS INC
Txns:
| Bought 25,000 shares
@ $1.54, valued at
$38.5k
|
|
02/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/31/2019 |
4
| ALTOMARI ALFRED (CEO) has filed a Form 4 on AGILE THERAPEUTICS INC
Txns:
| Granted 540,900 options to buy
@ $0.84, valued at
$454.4k
Granted 154,400 options to buy
@ $2.5, valued at
$386k
|
|
01/28/2019 |
4
| ALTOMARI ALFRED (CEO) has filed a Form 4 on AGILE THERAPEUTICS INC
Txns:
| Exercised 35,314 restricted stock units
@ $0 |
|
01/14/2019 |
4
| ALTOMARI ALFRED (Director) has filed a Form 4 on INSMED Inc
Txns:
| Sold 5,500 shares
@ $22.5, valued at
$123.8k
|
|
|